Antibodies

Details Antibodies Antibodies

2006-07-11

2006-07-11

Huff, S. (Department: 1643)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S325000, C435S069100

Reexamination Certificate

active

07074909

ABSTRACT:
The use of an ScFv Ab (ScFv Ab) capable of recognising a disease associated molecule (DAM) in the manufacture of a medicament for the prevention and/or treatment of a disease condition associated with a DAM is described. The ScFv Ab has therapeutic, diagnostic and prognostic applications.

REFERENCES:
patent: 5856140 (1999-01-01), Shimamura et al.
patent: 5876691 (1999-03-01), Chester et al.
patent: WO97/36932 (1997-10-01), None
patent: WO 98/55607 (1998-12-01), None
Reiger et al. (Glossary of Genetics and Cytogenetics, Classical and Molecular, 4th Ed., Springer-Verlay, Berlin, 1976.
Rudikoff et al (Proc Natl Acad Sci USA 1982 vol. 79 p. 1979.
Overbeek (1994, “Factors affecting transgenic animal production,” Transgenic animal technology, pp. 96-98.
(Wall, 1996 Theriogenology, vol. 45, pp. 57-68.
Mullins (1993, Hypertension, vol. 22, pp. 630-633.
Mullins (1990, Nature, vol. 344, 541-544.
Hammer (1990, Cell, vol. 63, 1099-1112.
Mullins, 1989, EMBO J., vol. 8, pp. 4065-4072.
Taurog, 1988, Jour. Immunol., vol. 141, pp. 4020-4023.
Mullins (1996, J. Clin. Invest. vol. 98, pp. S37-S40.
Chaudhary et al (PNAS 87:1066-1070, 1990.
Promega 1993/94 catalog of nucleic acids,p. 215-216.
Houdebine, 1994, J. Biotech. vol. 34, pp. 269-287.
Kappell, 1992, Current Opinions in Biotechnology, vol. 3, pp. 548-553.
Cameron, 1997, Molec. Biol. 7, pp. 253-265.
Niemann, 1997, Transg. Res. 7, pp. 73-75.
Forsberg, Göran, et al. “Identification of Framework Residues in a Secreted Recombinant Antibody Fragment That Control Production Level and Localization inEscherichis coli”,The Journal of Biological Chemistry, (1997) 272(19):12430-12436.

Affiliated with

Also associated with

Rating

Antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3564003